A patent review on cathepsin K inhibitors to treat osteoporosis (2011 – 2021) (2022)
Source: Expert Opinion on Therapeutic Patents. Unidade: IQSC
Subjects: BIOQUÍMICA, OSTEOPOROSE, NITRILAS
ABNT
ROCHO, Fernanda dos Reis; MONTANARI, Carlos Alberto; LEITÃO, Andrei; et al. A patent review on cathepsin K inhibitors to treat osteoporosis (2011 – 2021). Expert Opinion on Therapeutic Patents, Abingdon, v. 32, n. 5, p. 561-573, 2022. DOI: 10.1080/13543776.2022.2040480.APA
Rocho, F. dos R., Montanari, C. A., Leitão, A., Bonatto, V., Lameiro, R. da F., & Lameira, J. (2022). A patent review on cathepsin K inhibitors to treat osteoporosis (2011 – 2021). Expert Opinion on Therapeutic Patents, 32( 5), 561-573. doi:10.1080/13543776.2022.2040480NLM
Rocho F dos R, Montanari CA, Leitão A, Bonatto V, Lameiro R da F, Lameira J. A patent review on cathepsin K inhibitors to treat osteoporosis (2011 – 2021). Expert Opinion on Therapeutic Patents. 2022 ; 32( 5): 561-573.Vancouver
Rocho F dos R, Montanari CA, Leitão A, Bonatto V, Lameiro R da F, Lameira J. A patent review on cathepsin K inhibitors to treat osteoporosis (2011 – 2021). Expert Opinion on Therapeutic Patents. 2022 ; 32( 5): 561-573.